Modulated Imaging
Irvine, US · 3 known investors
Find your way into Modulated Imaging
Sign up to see every warm intro you have to Modulated Imaging
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Modulated Imaging team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Modulim develops microvascular imaging and data solutions that help clinicians assess and manage lower limb health in patients at risk of complications from diabetes, kidney disease, and peripheral arterial disease. Its technology supports proactive, data-driven care and connects providers digitally to help prevent amputations.
Founders & leadership
DC
David CucciaFounder
RO
Richard OberreiterExecutive
BT
Bruce TrombergNamed on SEC filing
Board
JR
Joseph RinehartBoard director
RL
Randall LunnBoard director
AC
Andrew CampbellBoard director
Investors · 3
Fresenius Medical Care VenturesreportedBad Homburg
How we know: funding news · Not right? Tell us
Mitsubishi UFJ CapitalreportedTokyo
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 3 rounds · 2016–2018
▶$7MraisedDec 2018 · 5 investors · Other TechnologyRule 506(b)
▶$7MraisedDec 2018 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David CucciaExecutive Officer, Director, Promoter
- Michael DuttonExecutive Officer
- Francis DuhayDirector
- Janelle GoulardDirector
- Keith BennettDirector
- Richard OberreiterExecutive Officer, Promoter
- Randall LunnDirector
- Offering amount
- $10M
- Amount sold
- $7M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedAug 2017 · 3 investors · Other TechnologyRule 506(b)
▶$2MraisedAug 2017 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph RinehartDirector
- Richard OberreiterExecutive Officer
- Randall LunnDirector
- David CucciaExecutive Officer, Director
- Bruce TrombergDirector
- Keith BennettDirector
- Offering amount
- $4M
- Amount sold
- $2M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJul 2016 · 2 investors · Other TechnologyRule 506(b)
▶$500KraisedJul 2016 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David CucciaExecutive Officer, Director
- Richard OberreiterExecutive Officer
- Joseph RinehartDirector
- Bruce TrombergDirector
- Randall LunnDirector
- Andrew CampbellDirector
- Offering amount
- $750K
- Amount sold
- $500K
- Minimum investment
- $25K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Modulated Imaging do?
- Modulim develops microvascular imaging and data solutions that help clinicians assess and manage lower limb health in patients at risk of complications from diabetes, kidney disease, and peripheral arterial disease. Its technology supports proactive, data-driven care and connects providers digitally to help prevent amputations.
- Who founded Modulated Imaging?
- Modulated Imaging was founded by David Cuccia.
- Who are Modulated Imaging's investors?
- Modulated Imaging's investors include Cove Fund, Fresenius Medical Care Ventures, Mitsubishi UFJ Capital.
- How much funding has Modulated Imaging raised?
- Modulated Imaging has disclosed $9.5M raised across 3 rounds.
- Where is Modulated Imaging headquartered?
- Modulated Imaging is headquartered in Irvine, US.
